Quinolones to treat acute bacterial exacerbation of chronic bronchitis in TB endemic areas: a word of caution.
نویسنده
چکیده
The meta-analysis by SIEMPOS et al. [1] has shown equivalent efficacy of macrolides, quinolones and amoxicillin/clavulanate in the treatment of patients with acute bacterial exacerbation of chronic bronchitis (ABECB). Although quinolones are associated with better microbiological success and fewer recurrences of ABECB, certain points merit further discussion, especially in tuberculosis (TB) endemic areas.
منابع مشابه
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
The comparative effectiveness and safety of macrolides, quinolones and amoxicillin/clavulanate (A/C) for the treatment of patients with acute bacterial exacerbation of chronic bronchitis (ABECB) was evaluated in the present study. PubMed, Current Contents and the Cochrane Central Register of Controlled Trials were searched to identify relevant randomised controlled trials (RCTs). In total, 19 R...
متن کاملGemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
The newest generation of fluoroquinolones have proven efficacy against bacterial organisms associated with acute exacerbation of chronic bronchitis (AECB). Gemifloxacin, as one of the quinolones in this class, exhibits many of the pharmacokinetic and pharmacodynamic characteristics of the class with a few notable differences. Against Streptococccus pneumoniae it has a lower minimal inhibitory c...
متن کاملTime does not heal all wounds: medical luminaries, national socialism, and the American College of Chest Physicians.
1 Dimopoulos G, Siempos II, Korbila IP, et al. Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a meta-analysis of randomized controlled trials. Chest 2007; 132:447–455 2 Wood-Baker RR, Gibson PG, Hannay M, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; 1:CD001...
متن کاملCOPD-3903-Gemifloxacin use in the treatment of acute bacter
Correspondence: Cristian Jivcu 1111 east McDowell road, Banner Good Samaritan Medical Center, Deparment of Internal Medicine, Phoenix, AZ, USA Tel +1 602 239 2296 Fax +1 602 239 2084 email [email protected] Abstract: The newest generation of fluoroquinolones have proven efficacy against bacterial organisms associated with acute exacerbation of chronic bronchitis (AECB). Gemifloxacin, as one of t...
متن کاملNEW DRUGS NEW DRUGS First-in-Class Antibiotic for Respiratory Infections
NEW DRUGS First-in-Class Antibiotic for Respiratory Infections The U.S. Food and Drug Administration (FDA) has approved telithromycin tablets (KetekTM, Aventis) in the U.S. to treat acute exacerbation of chronic bronchitis, acute bacterial sinusitis, and mildto-moderate community-acquired pneumonia, including infections caused by multidrug-resistant Streptococcus pneumoniae, in patients aged 18...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The European respiratory journal
دوره 30 6 شماره
صفحات -
تاریخ انتشار 2007